1. Home
  2. NBTB vs BCRX Comparison

NBTB vs BCRX Comparison

Compare NBTB & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NBT Bancorp Inc.

NBTB

NBT Bancorp Inc.

N/A

Current Price

$50.74

Market Cap

2.6B

Sector

Finance

ML Signal

N/A

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

N/A

Current Price

$8.12

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NBTB
BCRX
Founded
1856
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
NBTB
BCRX
Price
$50.74
$8.12
Analyst Decision
Hold
Buy
Analyst Count
7
11
Target Price
★ $56.83
$20.73
AVG Volume (30 Days)
268.6K
★ 4.1M
Earning Date
10-26-2026
11-02-2026
Dividend Yield
★ 3.19%
N/A
EPS Growth
12.12
★ 381.40
EPS
★ 1.99
N/A
Revenue
★ $182,952,000.00
$25,186,000.00
Revenue This Year
$8.99
N/A
Revenue Next Year
$5.50
$4.02
P/E Ratio
$25.27
★ N/A
Revenue Growth
★ 10.40
N/A
52 Week Low
$39.21
$6.00
52 Week High
$54.50
$11.22

Technical Indicators

Market Signals
Indicator
NBTB
BCRX
Relative Strength Index (RSI) 35.88 40.10
Support Level $41.60 $8.04
Resistance Level $51.09 $9.22
Average True Range (ATR) 0.80 0.28
MACD -0.16 -0.00
Stochastic Oscillator 0.00 33.49

Price Performance

Historical Comparison
NBTB
BCRX

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: